Wednesday, 8 March 2017

Principal Scientist – Computer-Aided Drug Design (CADD)

As a major element of Roche Pharma Research and Early Development (Roche pRED), the Therapeutic Modalities (TMo) function is responsible for creating innovative drug candidates for all Roche pRED Discovery and Translational areas (DTAs), spanning small molecules, biologics and nucleic acid-based therapeutics. As part of TMo, the Chemical Biology (CB) department focuses on the success of Roche’s preclinical pipeline by delivering leading edge science through strong expertise in high-throughput, D…

via http://ift.tt/1puljGF
Post a Comment